ExodusPoint Capital Management LP Purchases Shares of 190,150 Oscar Health, Inc. (NYSE:OSCR)

ExodusPoint Capital Management LP bought a new position in Oscar Health, Inc. (NYSE:OSCR - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 190,150 shares of the company's stock, valued at approximately $2,556,000. ExodusPoint Capital Management LP owned about 0.08% of Oscar Health as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also bought and sold shares of the stock. Vanguard Group Inc. lifted its position in Oscar Health by 3.2% during the fourth quarter. Vanguard Group Inc. now owns 18,997,973 shares of the company's stock valued at $255,333,000 after purchasing an additional 586,626 shares during the period. JPMorgan Chase & Co. boosted its stake in shares of Oscar Health by 348.7% in the 4th quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company's stock worth $139,246,000 after buying an additional 8,051,379 shares during the last quarter. State Street Corp grew its holdings in shares of Oscar Health by 6.0% in the third quarter. State Street Corp now owns 5,132,802 shares of the company's stock worth $108,867,000 after acquiring an additional 291,335 shares during the period. BIT Capital GmbH lifted its holdings in Oscar Health by 5,711.6% in the fourth quarter. BIT Capital GmbH now owns 4,473,853 shares of the company's stock valued at $60,129,000 after acquiring an additional 4,396,872 shares during the period. Finally, Geode Capital Management LLC boosted its position in Oscar Health by 3.0% in the fourth quarter. Geode Capital Management LLC now owns 4,468,098 shares of the company's stock worth $60,065,000 after purchasing an additional 128,458 shares during the last quarter. Institutional investors own 75.70% of the company's stock.

Remove Ads

Oscar Health Price Performance

Shares of OSCR stock traded up $0.34 on Friday, hitting $12.59. 3,640,827 shares of the stock traded hands, compared to its average volume of 3,868,096. The firm has a market cap of $3.15 billion, a price-to-earnings ratio of -629.19 and a beta of 1.75. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. The firm has a 50 day simple moving average of $14.02 and a two-hundred day simple moving average of $15.35. Oscar Health, Inc. has a 52 week low of $11.47 and a 52 week high of $23.79.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings results on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing analysts' consensus estimates of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. As a group, equities research analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, Wells Fargo & Company cut shares of Oscar Health from an "overweight" rating to an "equal weight" rating and dropped their price target for the stock from $20.00 to $16.00 in a research note on Thursday, March 13th. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating, two have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $20.21.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.